Global Trac Solutions, Inc. CEO, David Flores, sits down once again with Founder & CEO of The Third Wave, Paul F. Austin. The two begin their conversation with accessibility & affordability, concepts that are commonly overlooked in psychedelic medicine. They then dive into what it would take to create an infrastructure that ensures a very important segment of our society is able to gain access to the powerful, and profound benefits available through the use of psychedelic medicine.
Similar Posts
Meet Psilocybe stametsii, a New Mushroom Species Named After Paul Stamets
Mycologist Paul Stamets’ legacy will forever be remembered with a species bearing his name – Psilocybe stametsii.
Australia to Study Psilocybin for Meth Addiction
New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin.
United States’ First Actively Managed Psychedelics ETF Launches on NYSE Arca
PSIL is the third psychedelics ETF to hit the markets after the launch of the world’s first psychedelic ETF earlier this year.
Psychedelics Help Heal Childhood Trauma, Study Finds
Researchers find that there were significantly lower levels of complex trauma symptoms and feelings of internalized shame in study participants that had used psychedelics therapeutically.
Compass Pathways IPO Brings $1 Billion Valuation
UK-based Compass Pathways led a groundbreaking IPO last week. Share…
Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses
The psychedelic renaissance hits a rough patch as major companies look to tighten their belts or face total collapse. What’s happening with Psychedelic Stocks?